Used as a key intermediate in the synthesis of pharmaceutical agents, particularly in the development of selective estrogen receptor modulators (SERMs). Its structure supports the creation of compounds with activity in hormone-related therapies, including treatments for breast cancer and osteoporosis. The presence of the trifluoromethyl group enhances metabolic stability and binding affinity, making it valuable in medicinal chemistry for optimizing drug candidates. Also employed in research settings to explore new bioactive molecules and structure-activity relationships in steroid-like frameworks.